These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6732835)

  • 1. Monophosphates of formycin B and allopurinol riboside. Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase.
    Spector T; Jones TE; LaFon SW; Nelson DJ; Berens RL; Marr JJ
    Biochem Pharmacol; 1984 May; 33(10):1611-7. PubMed ID: 6732835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanosine 5'-monophosphate reductase from Leishmania donovani. A possible chemotherapeutic target.
    Spector T; Jones TE
    Biochem Pharmacol; 1982 Dec; 31(23):3891-7. PubMed ID: 7159467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and mechanism of action of formycin B in Leishmania.
    Rainey P; Santi DV
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):288-92. PubMed ID: 6572004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism.
    Marr JJ; Berens RL; Nelson DJ; Krenitsky TA; Spector T; LaFon SW; Elion GB
    Biochem Pharmacol; 1982 Jan; 31(2):143-8. PubMed ID: 7073876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylosuccinate synthetase and adenylosuccinate lyase from Trypanosoma cruzi, Specificity studies with potential chemotherapeutic agents.
    Spector T; Berens RL; Marr JJ
    Biochem Pharmacol; 1982 Jan; 31(2):225-9. PubMed ID: 7037007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine analogs. Their metabolism in mouse L cells and in Leishmania donovani.
    LaFon SW; Nelson DJ; Berens RL; Marr JJ
    J Biol Chem; 1985 Aug; 260(17):9660-5. PubMed ID: 4019491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.
    Nelson DJ; Bugge CJ; Elion GB; Berens RL; Marr JJ
    J Biol Chem; 1979 May; 254(10):3959-64. PubMed ID: 438170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical genetic analysis of formycin B action in Leishmania donovani.
    Robinson N; Kaur K; Emmett K; Iovannisci DM; Ullman B
    J Biol Chem; 1984 Jun; 259(12):7637-43. PubMed ID: 6203896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026.
    Neal RA; Croft SL; Nelson DJ
    Trans R Soc Trop Med Hyg; 1985; 79(1):122-8. PubMed ID: 3992630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of pyrazolopyrimidines in Leishmania donovani.
    Looker DL; Marr JJ; Berens RL
    J Biol Chem; 1986 Jul; 261(20):9412-5. PubMed ID: 2424909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.
    Looker DL; Martinez S; Horton JM; Marr JJ
    J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
    Berman JD; Rainey P; Santi DV
    J Exp Med; 1983 Jul; 158(1):252-7. PubMed ID: 6190980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of purine analogs against Leishmania tropica within human macrophages in vitro.
    Berman JD; Lee LS; Robins RK; Revankar GR
    Antimicrob Agents Chemother; 1983 Aug; 24(2):233-6. PubMed ID: 6638989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.
    Berens RL; Marr JJ; Looker DL; Nelson DJ; LaFon SW
    J Infect Dis; 1984 Oct; 150(4):602-8. PubMed ID: 6436394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana.
    Nolan LL; Berman JD; Giri L
    Biochem Int; 1984 Aug; 9(2):207-18. PubMed ID: 6207832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a mutant Leishmania donovani deficient in adenosine kinase activity.
    Iovannisci DM; Ullman B
    Mol Biochem Parasitol; 1984 Jun; 12(2):139-51. PubMed ID: 6090896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
    Berman JD
    J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative metabolism of a new antileishmanial agent, allopurinol riboside, in the parasite and the host cell.
    Nelson DJ; LaFon SW; Elion GB; Marr JJ; Berens RL
    Adv Exp Med Biol; 1979; 122B():7-12. PubMed ID: 546162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of formycin. Formation of formycin from formycin B.
    Ochi D; Yashima S; Eguchi Y
    J Antibiot (Tokyo); 1975 Dec; 28(12):965-73. PubMed ID: 1206009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of adenosine kinase in the phosphorylation of formycin B in CHO cells.
    Mehta KD; Gupta RS
    Biochem Biophys Res Commun; 1985 Jul; 130(2):910-7. PubMed ID: 2992490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.